Nasdaq Halts Moleculin Biotech Inc.

Rhea-AI Summary

The Nasdaq Stock Market (NDAQ) announced on May 18, 2020, that trading in Moleculin Biotech Inc. (MBRX) has been halted since May 4, due to a request for additional information from the company. The last sale price before the halt was $1.07. Trading will remain suspended until Moleculin Biotech provides the required information to Nasdaq.

Positive

• None.

Negative

• Trading in MBRX has been halted since May 4, indicating potential issues with the company.
• The halt was initiated due to Nasdaq's request for additional information, signaling regulatory concerns.

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market^® (Nasdaq: NDAQ) announced that the trading halt status in Moleculin Biotech Inc. (Nasdaq: MBRX) was changed to "additional information requested" from the company. Trading in the company’s stock had been halted on May 4, 2020 at 9:25:06 Eastern Time at a last sale price of $1.07.

Trading will remain halted until Moleculin Biotech Inc.has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotes^SM on the Nasdaq^® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Bianca Fata
Bianca.Fata@nasdaq.com

FAQ

Why was trading in Moleculin Biotech Inc. (MBRX) halted?

Trading was halted due to a request for additional information from Nasdaq.

When was Moleculin Biotech's trading halted?

Trading was halted on May 4, 2020.

What is the last sale price of Moleculin Biotech before the halt?

The last sale price was $1.07.

When will trading in Moleculin Biotech (MBRX) resume?

Trading will resume once the company satisfies Nasdaq's request for additional information.